Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence and prevalence of acute and chronic wounds, launch of novel wound dressing products, and increasing number of geriatric population with co-morbid conditions.
The hydrocolloid dressing market is segmented as below:
By Application
- Chronic wound
- Acute wound
By End-user
- Hospitals
- Clinics
- Others
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the hydrocolloid dressing market covers the following areas:
- Hydrocolloid dressing market sizing
- Hydrocolloid dressing market forecast
- Hydrocolloid dressing market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The publisher recognizes the following companies as the key players in the global hydrocolloid dressing market: 3M Co., AMERX Health Care Corp., B.Braun SE, Cardinal Health Inc., ConvaTec Group Plc, Covalon Technologies Ltd., DermaRite Industries LLC, Essity AB, Hollister Inc., Integra Lifesciences Corp., Johnson and Johnson, Lohmann and Rauscher GmbH and Co. KG, McKesson Corp., Medline Industries LP, Medtronic Plc, Molnlycke Health Care AB, Paul Hartmann AG, Roosin Medical Co. Ltd , Smith and Nephew plc, and Coloplast AS.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is emergence of nanoparticles to treat wounds.'
According to the report, one of the major drivers for this market is the increasing incidence and prevalence of acute and chronic wounds.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M Co.
- AMERX Health Care Corp.
- B.Braun SE
- Cardinal Health Inc.
- ConvaTec Group Plc
- Covalon Technologies Ltd.
- DermaRite Industries LLC
- Essity AB
- Hollister Inc.
- Integra Lifesciences Corp.
- Johnson and Johnson
- Lohmann and Rauscher GmbH and Co. KG
- McKesson Corp.
- Medline Industries LP
- Medtronic Plc
- Molnlycke Health Care AB
- Paul Hartmann AG
- Roosin Medical Co. Ltd
- Smith and Nephew plc
- Coloplast AS